Cannabis Suisse (CSUI) Cost of Revenue (2016 - 2025)

Cannabis Suisse (CSUI) has 9 years of Cost of Revenue data on file, last reported at $7356.0 in Q1 2025.

• On a quarterly basis, Cost of Revenue rose 6.98% year-over-year to $7356.0 in Q1 2025; TTM through Nov 2025 was $7356.0, a 76.29% decrease from a year earlier, with the FY2025 full-year figure at $22068.0, down 26.6% from the prior year.
• Cost of Revenue for Q1 2025 stood at $7356.0, roughly flat from $7356.0 in the prior quarter.
• Over the last five years, Cost of Revenue for CSUI reached as high as $65703.0 in Q2 2021 and fell as low as $1734.0 in Q4 2021.
• Historically, Cost of Revenue has averaged $10872.7 across 5 years, with a median of $6875.5 in 2023.
• Across the five-year window, Cost of Revenue tumbled 97.36% in 2022 and soared 296.42% in 2023, its largest moves.
• Year by year, Cost of Revenue stood at $1734.0 in 2021, then changed by 0.0% to $1734.0 in 2022, then surged by 296.42% to $6874.0 in 2023, then gained by 7.01% to $7356.0 in 2024, then changed by 0.0% to $7356.0 in 2025.
• Per Business Quant data, the three most recent Cost of Revenue figures were $7356.0 in Q1 2025, $7356.0 in Q4 2024, and $7356.0 in Q3 2024.